As the disease becomes more pervasive and the need for treatment increases, a slew of new prescription medications for those diagnosed with Type 2 diabetes have been approved by the Food and Drug Administration (FDA). But just because they have the august agency’s imprimatur does not necessarily make them safe. Take, for example, the case of Actos (pioglitazone).
A popular, widely-prescribed pill, Actos was approved by the FDA way back in 1999. Since that time, however, numerous studies have linked the medication with an increased risk of bladder cancer, especially when it is used for more than one year. At present, there are countless Actos lawsuits pending in courthouses across the nation; some estimates put the number of future cases as high as 10,000!
Filling a case
Because the research has established a clear link between pioglitazone use and bladder cancer, patients who can demonstrate through their medical records that they suffer from the illness after prolonged Actos usage are likely to win a jury verdict or case settlement. As it has a number of other side effects, patients who experience serious consequences of Actos usages should contact a personal injury or medical malpractice attorney as soon as possible.